Ollivier Hyrien
Concepts (248)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
Models, Biological | 10 | 2001 | 410 |
Why?
| Oligodendroglia | 6 | 2005 | 25 |
Why?
| Models, Statistical | 5 | 2003 | 114 |
Why?
| Stochastic Processes | 6 | 2001 | 22 |
Why?
| Mutagens | 5 | 1999 | 29 |
Why?
| Stem Cells | 5 | 2005 | 107 |
Why?
| Micronucleus Tests | 6 | 2001 | 9 |
Why?
| Models, Theoretical | 2 | 2009 | 124 |
Why?
| Carmustine | 1 | 2010 | 25 |
Why?
| Succinimides | 1 | 2010 | 12 |
Why?
| Antineoplastic Agents, Alkylating | 1 | 2010 | 30 |
Why?
| Flow Cytometry | 2 | 2007 | 216 |
Why?
| Fluoresceins | 1 | 2010 | 50 |
Why?
| Reticulocytes | 5 | 2007 | 23 |
Why?
| Clone Cells | 4 | 2005 | 92 |
Why?
| Aza Compounds | 2 | 2006 | 13 |
Why?
| Neuroglia | 1 | 2010 | 49 |
Why?
| Quinolines | 2 | 2006 | 26 |
Why?
| Cell Lineage | 1 | 2009 | 60 |
Why?
| Cell Differentiation | 6 | 2005 | 262 |
Why?
| Micronuclei, Chromosome-Defective | 5 | 2007 | 9 |
Why?
| Delayed Rectifier Potassium Channels | 2 | 2006 | 8 |
Why?
| Gamma Rays | 4 | 2005 | 38 |
Why?
| Lymphoma, Follicular | 3 | 2009 | 27 |
Why?
| Electrocardiography | 2 | 2006 | 132 |
Why?
| Arrhythmias, Cardiac | 1 | 2006 | 65 |
Why?
| Lymphocytes, Tumor-Infiltrating | 2 | 2009 | 20 |
Why?
| Carcinoma, Non-Small-Cell Lung | 2 | 2008 | 23 |
Why?
| Dose-Response Relationship, Radiation | 8 | 2005 | 85 |
Why?
| CD8-Positive T-Lymphocytes | 2 | 2009 | 91 |
Why?
| Statistical Distributions | 2 | 2005 | 7 |
Why?
| Cell Death | 3 | 2005 | 94 |
Why?
| Humans | 21 | 2005 | 1856 |
Why?
| Cell Division | 3 | 2005 | 273 |
Why?
| Bone Marrow Cells | 3 | 1999 | 92 |
Why?
| Cell Proliferation | 3 | 2005 | 227 |
Why?
| Cells, Cultured | 6 | 2005 | 447 |
Why?
| Anti-Infective Agents | 2 | 2006 | 54 |
Why?
| Lung Neoplasms | 2 | 2008 | 159 |
Why?
| Computer Simulation | 3 | 2005 | 134 |
Why?
| Animals | 14 | 1999 | 1031 |
Why?
| Mutation | 2 | 2009 | 340 |
Why?
| Radiometry | 2 | 2010 | 31 |
Why?
| Long QT Syndrome | 2 | 2006 | 35 |
Why?
| Pressure | 2 | 2009 | 79 |
Why?
| Whole-Body Irradiation | 2 | 2007 | 43 |
Why?
| 6-Mercaptopurine | 2 | 2001 | 4 |
Why?
| Rats | 5 | 1999 | 530 |
Why?
| Immunologic Memory | 2 | 2009 | 51 |
Why?
| Cell Growth Processes | 1 | 2010 | 24 |
Why?
| T-Lymphocytes, Helper-Inducer | 1 | 2011 | 38 |
Why?
| HeLa Cells | 2 | 2005 | 107 |
Why?
| Membrane Proteins | 3 | 2009 | 233 |
Why?
| Taxoids | 1 | 2010 | 12 |
Why?
| Mice | 9 | 2001 | 623 |
Why?
| Neutrophils | 2 | 2009 | 114 |
Why?
| Erythrocytes | 2 | 2003 | 109 |
Why?
| Skin Physiological Phenomena | 1 | 2010 | 11 |
Why?
| Radiation-Sensitizing Agents | 1 | 2010 | 29 |
Why?
| Toxicity Tests | 1 | 2010 | 17 |
Why?
| Apyrase | 1 | 2009 | 12 |
Why?
| Cell Cycle | 3 | 2003 | 121 |
Why?
| Clonal Anergy | 1 | 2009 | 20 |
Why?
| Biological Assay | 1 | 2010 | 58 |
Why?
| Models, Neurological | 1 | 2010 | 59 |
Why?
| Lymph Nodes | 1 | 2011 | 106 |
Why?
| Cell Shape | 1 | 2009 | 20 |
Why?
| Chromosome Aberrations | 1 | 2010 | 45 |
Why?
| Radiation Tolerance | 1 | 2010 | 37 |
Why?
| CpG Islands | 1 | 2009 | 26 |
Why?
| Interleukins | 1 | 2009 | 32 |
Why?
| Cell Adhesion Molecules | 1 | 2009 | 48 |
Why?
| Radiation Injuries, Experimental | 1 | 2009 | 37 |
Why?
| T-Lymphocytes, Regulatory | 1 | 2009 | 32 |
Why?
| Probability | 2 | 2006 | 190 |
Why?
| Antibodies, Neoplasm | 1 | 2009 | 28 |
Why?
| B-Lymphocyte Subsets | 1 | 2009 | 33 |
Why?
| Oligodeoxyribonucleotides | 1 | 2009 | 86 |
Why?
| CD40 Ligand | 1 | 2009 | 51 |
Why?
| Pneumonectomy | 1 | 2008 | 15 |
Why?
| DNA Repair | 2 | 2005 | 47 |
Why?
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 23 |
Why?
| Stem Cell Transplantation | 1 | 2009 | 50 |
Why?
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 38 |
Why?
| Antibody Formation | 1 | 2009 | 89 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2009 | 121 |
Why?
| Paclitaxel | 1 | 2008 | 37 |
Why?
| Histones | 1 | 2010 | 42 |
Why?
| Pancreatic Neoplasms | 1 | 2008 | 46 |
Why?
| Cesium Radioisotopes | 1 | 2007 | 18 |
Why?
| Thromboplastin | 1 | 2008 | 21 |
Why?
| Portal Vein | 1 | 2007 | 30 |
Why?
| Antigens, CD | 1 | 2009 | 128 |
Why?
| Carcinoma, Hepatocellular | 1 | 2007 | 53 |
Why?
| Antibodies, Monoclonal | 2 | 2009 | 241 |
Why?
| Skin | 1 | 2010 | 177 |
Why?
| Male | 11 | 1999 | 1553 |
Why?
| Cell Membrane | 1 | 2009 | 170 |
Why?
| Immunoglobulin G | 1 | 2009 | 191 |
Why?
| Venous Thromboembolism | 1 | 2008 | 15 |
Why?
| Female | 11 | 2003 | 1643 |
Why?
| Liver Neoplasms | 1 | 2007 | 97 |
Why?
| Life Tables | 1 | 2006 | 33 |
Why?
| Time | 1 | 2006 | 41 |
Why?
| Thyroid Hormones | 1 | 2006 | 23 |
Why?
| Monte Carlo Method | 1 | 2006 | 40 |
Why?
| Algorithms | 2 | 2006 | 226 |
Why?
| Video Recording | 1 | 2006 | 46 |
Why?
| Fibroblasts | 1 | 2010 | 179 |
Why?
| Optic Nerve | 1 | 2006 | 27 |
Why?
| Cell Aging | 1 | 2006 | 31 |
Why?
| Mutagenesis | 2 | 2003 | 74 |
Why?
| Mutagenicity Tests | 2 | 1999 | 11 |
Why?
| Cells | 1 | 2005 | 16 |
Why?
| Adult | 7 | 2005 | 1317 |
Why?
| Placebos | 1 | 2006 | 110 |
Why?
| Statistics, Nonparametric | 1 | 2006 | 141 |
Why?
| Thrombosis | 1 | 2007 | 105 |
Why?
| Radiation Pneumonitis | 1 | 2005 | 12 |
Why?
| Biometry | 1 | 2005 | 32 |
Why?
| T-Lymphocytes | 1 | 2009 | 182 |
Why?
| Mitosis | 1 | 2005 | 68 |
Why?
| Cell Culture Techniques | 1 | 2005 | 74 |
Why?
| Cell Count | 1 | 2005 | 163 |
Why?
| Interleukin-1 | 1 | 2005 | 109 |
Why?
| Antineoplastic Agents | 1 | 2009 | 190 |
Why?
| Antimetabolites, Antineoplastic | 1 | 2003 | 29 |
Why?
| Kinetics | 2 | 2001 | 349 |
Why?
| Brain | 1 | 2010 | 305 |
Why?
| Interleukin-6 | 1 | 2005 | 145 |
Why?
| Numerical Analysis, Computer-Assisted | 1 | 2001 | 5 |
Why?
| Markov Chains | 1 | 2001 | 25 |
Why?
| Erythropoiesis | 1 | 2001 | 25 |
Why?
| Mice, Inbred C57BL | 3 | 2009 | 318 |
Why?
| Follow-Up Studies | 3 | 2008 | 553 |
Why?
| Rats, Wistar | 2 | 2009 | 75 |
Why?
| Nitriles | 1 | 1999 | 27 |
Why?
| Remission Induction | 2 | 2009 | 64 |
Why?
| Radiation Dosage | 2 | 2010 | 65 |
Why?
| Etoposide | 1 | 1999 | 37 |
Why?
| Aged | 5 | 2005 | 988 |
Why?
| Antibodies, Monoclonal, Murine-Derived | 2 | 2009 | 33 |
Why?
| DNA Damage | 1 | 1999 | 66 |
Why?
| Microscopy, Fluorescence | 2 | 2009 | 137 |
Why?
| Drug Administration Schedule | 2 | 2008 | 191 |
Why?
| Time Factors | 4 | 1999 | 896 |
Why?
| Cell Line, Tumor | 2 | 2009 | 208 |
Why?
| Middle Aged | 5 | 2005 | 1161 |
Why?
| Retrospective Studies | 3 | 2007 | 653 |
Why?
| Reproducibility of Results | 2 | 2010 | 391 |
Why?
| Neoplasm Staging | 2 | 2007 | 125 |
Why?
| Aged, 80 and over | 3 | 2005 | 599 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2005 | 224 |
Why?
| Cell Survival | 2 | 2005 | 229 |
Why?
| Predictive Value of Tests | 2 | 2005 | 321 |
Why?
| Sensitivity and Specificity | 2 | 2005 | 427 |
Why?
| Rats, Sprague-Dawley | 2 | 1999 | 257 |
Why?
| Receptors, CXCR5 | 1 | 2011 | 7 |
Why?
| Microarray Analysis | 1 | 2011 | 24 |
Why?
| Cluster Analysis | 1 | 2011 | 66 |
Why?
| Forkhead Transcription Factors | 1 | 2011 | 44 |
Why?
| Neurotrophin 3 | 1 | 2010 | 6 |
Why?
| Tumor Stem Cell Assay | 1 | 2010 | 21 |
Why?
| Dose Fractionation | 1 | 2010 | 25 |
Why?
| Translational Medical Research | 1 | 2010 | 20 |
Why?
| Pore Forming Cytotoxic Proteins | 1 | 2010 | 6 |
Why?
| Granulocyte Colony-Stimulating Factor | 1 | 2010 | 34 |
Why?
| Antigens, CD59 | 1 | 2010 | 4 |
Why?
| 4-Nitroquinoline-1-oxide | 1 | 2009 | 2 |
Why?
| Methylnitrosourea | 1 | 2009 | 6 |
Why?
| Ethylnitrosourea | 1 | 2009 | 10 |
Why?
| Benzo(a)pyrene | 1 | 2009 | 7 |
Why?
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2009 | 14 |
Why?
| Cisplatin | 1 | 2010 | 43 |
Why?
| Terrorism | 1 | 2010 | 9 |
Why?
| Triazines | 1 | 2009 | 20 |
Why?
| Bioreactors | 1 | 2009 | 8 |
Why?
| Tissue Array Analysis | 1 | 2010 | 27 |
Why?
| Receptors, Purinergic P1 | 1 | 2009 | 19 |
Why?
| NIH 3T3 Cells | 1 | 2009 | 22 |
Why?
| L-Selectin | 1 | 2009 | 11 |
Why?
| Bacterial Toxins | 1 | 2010 | 24 |
Why?
| Microvilli | 1 | 2009 | 15 |
Why?
| Microscopy, Electron, Transmission | 1 | 2009 | 31 |
Why?
| Macrophage-1 Antigen | 1 | 2009 | 11 |
Why?
| Lasers | 1 | 2009 | 35 |
Why?
| Mice, Inbred C3H | 1 | 2010 | 86 |
Why?
| Vincristine | 1 | 2009 | 27 |
Why?
| Triazoles | 1 | 2009 | 31 |
Why?
| Lymphocyte Function-Associated Antigen-1 | 1 | 2009 | 10 |
Why?
| Fluorescence | 1 | 2009 | 46 |
Why?
| Salvage Therapy | 1 | 2009 | 37 |
Why?
| Adenosine | 1 | 2009 | 57 |
Why?
| Imaging, Three-Dimensional | 1 | 2010 | 58 |
Why?
| Transplantation, Autologous | 1 | 2009 | 78 |
Why?
| Pyrimidines | 1 | 2009 | 49 |
Why?
| Species Specificity | 1 | 2010 | 186 |
Why?
| Longitudinal Studies | 1 | 2010 | 195 |
Why?
| Adolescent | 2 | 2008 | 891 |
Why?
| Doxorubicin | 1 | 2009 | 60 |
Why?
| Pilot Projects | 1 | 2010 | 264 |
Why?
| Cyclophosphamide | 1 | 2009 | 82 |
Why?
| Biopsy | 1 | 2010 | 207 |
Why?
| Combined Modality Therapy | 1 | 2010 | 219 |
Why?
| Gene Expression Profiling | 1 | 2011 | 138 |
Why?
| Immunotherapy | 1 | 2009 | 48 |
Why?
| Immunity, Cellular | 1 | 2009 | 85 |
Why?
| Prednisone | 1 | 2009 | 80 |
Why?
| Neuroprotective Agents | 1 | 2009 | 60 |
Why?
| Interleukin-2 | 1 | 2009 | 71 |
Why?
| Infusions, Intravenous | 1 | 2008 | 87 |
Why?
| Environmental Exposure | 1 | 2010 | 75 |
Why?
| Interferon-gamma | 1 | 2009 | 133 |
Why?
| Recombinant Proteins | 1 | 2010 | 290 |
Why?
| Diagnosis, Computer-Assisted | 1 | 2008 | 39 |
Why?
| Adenosine Triphosphate | 1 | 2009 | 121 |
Why?
| Kaplan-Meier Estimate | 1 | 2007 | 89 |
Why?
| Lymphocyte Activation | 1 | 2009 | 137 |
Why?
| Survival Analysis | 1 | 2009 | 205 |
Why?
| Analysis of Variance | 1 | 2009 | 339 |
Why?
| Neoplasm Recurrence, Local | 1 | 2009 | 118 |
Why?
| DNA-Binding Proteins | 1 | 2011 | 204 |
Why?
| Membrane Glycoproteins | 1 | 2009 | 154 |
Why?
| Multivariate Analysis | 1 | 2007 | 225 |
Why?
| Young Adult | 1 | 2009 | 380 |
Why?
| Logistic Models | 1 | 2008 | 251 |
Why?
| New York | 1 | 2010 | 422 |
Why?
| Age Factors | 1 | 2009 | 480 |
Why?
| Cytokines | 1 | 2009 | 207 |
Why?
| Incidence | 1 | 2007 | 336 |
Why?
| ROC Curve | 1 | 2005 | 80 |
Why?
| Neoplasms, Radiation-Induced | 1 | 2005 | 31 |
Why?
| Severity of Illness Index | 1 | 2008 | 358 |
Why?
| Tomography, X-Ray Computed | 1 | 2008 | 321 |
Why?
| Injections, Intraperitoneal | 1 | 2003 | 57 |
Why?
| Biological Markers | 1 | 2005 | 262 |
Why?
| Mice, Inbred Strains | 1 | 2003 | 118 |
Why?
| Risk Factors | 1 | 2007 | 555 |
Why?
| Prospective Studies | 1 | 2005 | 545 |
Why?
| Treatment Outcome | 1 | 2008 | 661 |
Why?
| Blood Cells | 1 | 1999 | 19 |
Why?
| Organ Specificity | 1 | 1999 | 104 |
Why?
| CHO Cells | 1 | 1999 | 65 |
Why?
| Thymus Gland | 1 | 1999 | 57 |
Why?
| Intestines | 1 | 1999 | 83 |
Why?
| Cricetinae | 1 | 1999 | 130 |
Why?
| Kidney | 1 | 1999 | 223 |
Why?
| Liver | 1 | 1999 | 248 |
Why?
|
|
Hyrien's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|
